Kobo Biotech Q3 FY24 Results Live : Loss Rise by 3.38% YOY
Kobo Biotech declared their Q3 FY24 results on 14 Feb, 2024. The topline decreased by 0% & the loss increased by 3.38% YoY.
Compared to the previous quarter, the revenue declined by 0% and the loss increased by 1.29%. The Selling, general & administrative expenses rose by 7.6% q-o-q and increased by 18.36% Y-o-Y.
The operating income was down by 1.28% q-o-q and decreased by 3.38% Y-o-Y. The EPS is ₹-0.52 for Q3 FY24 which decreased by 4% Y-o-Y.
Kobo Biotech has delivered -5.62% return in the last 1 week, 60.31% return in the last 6 months, and 68.06% YTD return. Currently, Kobo Biotech has a market cap of ₹12.41 Cr and a 52-week high/low of ₹6.01 & ₹1.86 respectively.FAQsQuestion : What is the Q3 FY24 profit/Loss as per company?Ans : ₹-1.23CrQuestion : What is Q3 FY24 revenue?Ans : ₹0Cr Stay updated on quarterly results with our results calendarMilestone Alert!
Livemint tops charts as the fastest growing news website in the world
